我何时应该选择 eCTD 供应商来进行我的监管申报？
As your company moves towards the regulatory submission of a marketing application to a health…
Certara2022 年 1 月 10 日
Certara University Express Webinar: Part 2: Introduction to RsNLME and overview of expanded workflow
RsNLME 简介及其群体 PK/PD 建模功能。
Certara2022 年 1 月 5 日
Certara University Express Webinar: Part 1: Introduction to RsNLME (R speaks NLME)
RsNLME 简介及其群体 PK/PD 建模功能。
Certara2022 年 1 月 5 日
Certara Acquires Integrated Nonclinical Development Solutions
Expands software portfolio and nonclinical drug development expertise PRINCETON, N.J.— Jan 5, 2022– Certara, Inc.,…
Certara2022 年 1 月 5 日
Strategic Application of PBPK Modeling for Predicting DDIs & the Effects of Smoking & Organ Impairment
Olanzapine is a highly effective antipsychotic, but its uses are limited by the risk of…
Certara2021 年 12 月 23 日
ScienceDirect: Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: The TOGETHER randomized platform clinical trial
Observational studies have postulated a therapeutic role of metformin in treating COVID-19. We conducted ...(cont.)
Certara2021 年 12 月 22 日
Certara Announces FDA Renewal and Expansion of Certara’s Biosimulation Software for Reviewing Regulatory Submissions
FDA holds more than 400 SimcypTM and PhoenixTM software licenses across 12 divisions and offices…
Certara2021 年 12 月 21 日
P21 Releases New PMDA Validation Engine
New PMDA Engine Pinnacle 21 is happy to announce the latest Validation Engine for submissions…
Certara2021 年 12 月 20 日
A Bird’s Eye View on Rare Diseases: Key Drug Development Considerations for Thyroid Eye Disease
New therapeutics discovery and development for ocular diseases have been traditionally associated with a low…
Certara2021 年 12 月 15 日
